IMMONC

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
January, 2025
January 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  

IMMONC
Jan 10, 2025, 05:40 | Science
Article of the Week, Suggested by the BPDCN International Registry
Immune Oncology Research Institute shared a post on LinkedIn: “Article of the Week Suggested by the BPDCN International…
Nov 29, 2024, 13:43 | Insight
Article of the Week, Suggested by the BPDCN International Registry
Immune Oncology Research Institute shared a post on LinkedIn: “Article of the Week Suggested by the BPDCN International…
Nov 22, 2024, 14:36 | Opinion
Article of the Week, Suggested by the BPDCN International Registry
Immune Oncology Research Institute shared a post on LinkedIn: “Article of the Week Suggested by the BPDCN International…
Nov 15, 2024, 13:56 | Insight
Article of the Week, Suggested by the BPDCN International Registry
Immune Oncology Research Institute shared a post on LinkedIn: “Article of the Week Suggested by the BPDCN…
Oct 25, 2024, 12:34 | Insight
Article of the Week, Suggested by the BPDCN International Registry
Immune Oncology Research Institute shared a post on LinkedIn: “Article of the Week Suggested by the BPDCN International…
Oct 19, 2024, 09:50 | Insight
Updates on the GI and Neuroendocrine Tumors working group
Immune Oncology Research Institute shared a post on LinkedIn: "During its first year, the GI…
Oct 10, 2024, 13:09 | Insight
Article of the Week, Suggested by the BPDCN International Registry
Immune Oncology Research Institute shared a post on LinkedIn: “Article of the Week Suggested by the…
Oct 3, 2024, 12:54 | Insight
Article of the Week, Suggested by the BPDCN International Registry
Immune Oncology Research Institute shared a post on LinkedIn: “Article of the Week Suggested by the…
Sep 24, 2024, 16:52 | Blog
Assessment of the safety and efficacy of Balstilimab in combination with Botensilimab for NSCLC - Immune Oncology Research Institute
Immune Oncology Research Institute shared a post on LinkedIn: ''Assessment of the safety and efficacy…
Sep 19, 2024, 11:07 | Insight
Article of the Week, Suggested by the BPDCN International Registry
Immune Oncology Research Institute shared a post on LinkedIn: "Article of the Week Suggested by…
Sep 18, 2024, 06:44 | Blog
Shushan Hovsepyan is appointed as Innovation and Development Director at IMMONC
IMMONC (Immune Oncology Research Institute) shared a post on LinkedIn: ''We are pleased to announce,…
Sep 14, 2024, 09:43 | Insight
Article of the day, September 14th, suggested by the Immune Oncology Research Institute
Immune Oncology Research Institute shared a post on LinkedIn: “Article of the day! Suggest by the Immune…
Sep 13, 2024, 13:59 | Insight
Article of the day, September 13th, suggested by the Immune Oncology Research Institute
Immune Oncology Research Institute shared a post on LinkedIn: “Article of the day! Suggest by the Immune…
Sep 11, 2024, 05:15 | Insight
Article of the day, September 11th, suggested by the Immune Oncology Research Institute
Immune Oncology Research Institute shared a post on LinkedIn: “Article of the day! Suggest by the Immune…
Sep 10, 2024, 14:57 | Insight
Article of the day, September 10th, suggested by the Immune Oncology Research Institute
Immune Oncology Research Institute shared a post on LinkedIn: “Article of the day! Suggest by the Immune…
Sep 9, 2024, 13:18 | Insight
Article of the day, September 9th, suggested by the Immune Oncology Research Institute
Immune Oncology Research Institute shared a post on LinkedIn: “Article of the day! Suggest by the Immune…
Sep 8, 2024, 14:09 | Insight
Article of the day, September 8th, suggested by the Immune Oncology Research Institute
Immune Oncology Research Institute shared a post on LinkedIn: “Article of the day! Suggest by the Immune…
Sep 6, 2024, 12:58 | Insight
Article of the day, September 6th, suggested by the Immune Oncology Research Institute
Immune Oncology Research Institute shared a post on LinkedIn: “Article of the day! Suggest by the Immune…
Sep 5, 2024, 15:04 | Insight
Article of the day, September 5th, suggested by the Immune Oncology Research Institute
Immune Oncology Research Institute shared a post on LinkedIn: “Article of the day! Suggest by the Immune…
Sep 4, 2024, 10:54 | Insight
Article of the day, September 4th, suggested by the Immune Oncology Research Institute
Immune Oncology Research Institute shared a post on LinkedIn: “Article of the day! Suggest by the Immune…
Sep 3, 2024, 14:47 | Insight
Article of the day, September 3rd, suggested by the Immune Oncology Research Institute
Immune Oncology Research Institute shared a post on LinkedIn: “Article of the day! Suggest by the Immune…
Sep 2, 2024, 13:49 | Insight
Article of the day, September 2nd, suggested by the Immune Oncology Research Institute
Immune Oncology Research Institute shared a post on LinkedIn: “Article of the day! Suggest by the Immune…
Sep 1, 2024, 10:46 | Insight
Article of the day, September 1st, suggested by the Immune Oncology Research Institute
Immune Oncology Research Institute shared a post on LinkedIn: “Article of the day! Suggest by the Immune…
Aug 31, 2024, 09:52 | Insight
Article of the day, August 31st, suggested by the Immune Oncology Research Institute
Immune Oncology Research Institute shared a post on LinkedIn: “Article of the day! Suggest by the Immune…
Aug 30, 2024, 10:39 | Insight
Article of the day, August 30th, suggested by the Immune Oncology Research Institute
Immune Oncology Research Institute shared a post on LinkedIn: “Article of the day! Suggest by the Immune…
Aug 29, 2024, 11:25 | Insight
Article of the day, August 29th, suggested by the Immune Oncology Research Institute
Immune Oncology Research Institute shared a post on LinkedIn: “Article of the day! Suggest by the Immune…
Aug 8, 2024, 02:09 | Blog
Immune Oncology Research Institute at the ASCO 2024 Annual Meeting
Immune Oncology Research Institute made the following post on LinkedIn: "IMMONC at the ASCO 2024 Annual…
Jul 13, 2024, 09:41 | Insight
IMMONC - Immune Oncology Research Institute's Experience in Advancing Clinical Cancer Research in Armenia
Cancer affects people across the world regardless of their socioeconomic status. However, low- and middle-income…
May 30, 2024, 10:57 | Insight
Julia Hoveyan: A year ago, the IMMONC launched the first-ever investigator-sponsored trial in pediatric oncology in Armenia
Ruzanna Papyan recently shared a post by Julia Hoveyan, Pediatric Oncologist at the Pediatric Cancer…
Apr 15, 2024, 04:04 | Blog
Amalya Sargsyan: Proud to see IMMONC spotlighted in ASCO's latest policy statement on global equity in clinical trials
Amalya Sargsyan, Medical Oncologist at Yeolyan Hematology and Oncology Center, posted on LinkedIn: "Extremely proud to…
Feb 14, 2024, 13:40 | Insight
Karen Bedirian: Happy to share that IMMONC received regulatory approval to conduct a trial of BAL+BOT among patients with metastatic non-small cell lung cancer
Karen Bedirian, Projects Director at Immune Oncology Research Institute, shared on LinkedIn: "Happy to share…
Feb 8, 2024, 16:56 | Blog
IV Armenian Oncology Congress: 6 tweets from Shushan Hovsepyan
Shushan Hovsepyan, Pediatric Oncologist and Clinical Research Coordinator at the Yeolyan Hematology and Oncology Center,…
Jan 15, 2024, 08:37 | Career
Jemma Arakelyan: I have been ranked in the top 5% of PG researchers and have received Excellent Paper Awards
Jemma Arakelyan, CEO of the Institute of Cancer and Crisis, shared on LinkedIn: "Delighted to…
Jun 13, 2023, 17:24 | Insight
In 16 months, we have registered more cancer clinical trials in Armenia, than throughout all the years before that - Gevorg Tamamyan
Last year, on February 4th I was doing a presentation about the cancer clinical trials…
All: 34 Posts: 1 - 100
Special Coverage